SYMBRAVO is thought to work differently
SYMBRAVO combines rizatriptan, one of the most prescribed migraine treatments, with long-lastinga meloxicam and MoSEIC™ technology to create a novel migraine medication. While most migraine medicines only address 1 of the key factors that cause migraine pain (PGE2 or CGRP), SYMBRAVO may address both.
- a
- Long-lasting refers to duration of medication in blood. Blood levels do not necessarily tie to efficacy.
No combination of generic meloxicam and rizatriptan will result in the same amounts of drug reaching the bloodstream as SYMBRAVO because of its formulation
The exact way that SYMBRAVO works to treat migraine is unclear, and whether MoSEIC™ (Molecular Solubility Enhanced Inclusion Complex) has an impact on the effectiveness of SYMBRAVO has not been established. The reason for the faster absorption seen with rizatriptan in SYMBRAVO is unknown.

LEARN MORE REASONSTO CONSIDER SYMBRAVO
See clinical study results